Health Promot Perspect. 2020;10(4): 373-382. doi: 10.34172/hpp.2020.56

Original Article

Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial

Helda Tutunchi 1 ORCID, Fatemeh Naeini 2, Maryam Saghafi-Asl 1, Nazila Farrin 1, Alireza Monshikarimi 1 * , Alireza Ostadrahimi 1 * ORCID

Cited by CrossRef: 3

1- Murillo‐Rodríguez E, Arankowsky‐Sandoval G, Budde H, Imperatori C, Machado S, Yamamoto T, Yadollahpour A, Torterolo P. In vivo brain levels of acetylcholine and 5‐hydroxytryptamine after oleoylethanolamide or palmitoylethanolamide administrations are mediated by PPARα engagement. Eur J Neurosci. 2021;54(6):5932 [Crossref]
2- Komolafe O, Buzzetti E, Linden A, Best L, Madden A, Roberts D, Chase T, Fritche D, Freeman S, Cooper N, Sutton A, Milne E, Wright K, Pavlov C, Davidson B, Tsochatzis E, Gurusamy K. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. 2021;2021(7) [Crossref]
3- Giudetti A, Vergara D, Longo S, Friuli M, Eramo B, Tacconi S, Fidaleo M, Dini L, Romano A, Gaetani S. Oleoylethanolamide Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in High-Fat Diet-Fed Rats. Antioxidants. 2021;10(8):1289 [Crossref]

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission

Indexing and Abstracting

Image result for esci

  Image result for scopus

Scimago Journal & Country Rank

Officially associated with

The Iranian Health Education & Promotion Association